CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
CYP27A1 expression is associated with risk of late lethal estrogen receptor-positive breast cancer in postmenopausal patients ; volume:22 ; number:1 ; day:11 ; month:11 ; year:2020 ; pages:1-13 ; date:12.2020
Breast cancer research ; 22, Heft 1 (11.11.2020), 1-13, 12.2020
- Creator
-
Kimbung, Siker
Inasu, Maria
Stålhammar, Tor
Nodin, Björn
Elebro, Karin
Tryggvadottir, Helga
Ygland Rödström, Maria
Jirström, Karin
Isaksson, Karolin
Jernström, Helena
Borgquist, Signe
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13058-020-01347-x
- URN
-
urn:nbn:de:101:1-2020122219084530672949
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kimbung, Siker
- Inasu, Maria
- Stålhammar, Tor
- Nodin, Björn
- Elebro, Karin
- Tryggvadottir, Helga
- Ygland Rödström, Maria
- Jirström, Karin
- Isaksson, Karolin
- Jernström, Helena
- Borgquist, Signe
- SpringerLink (Online service)
Other Objects (12)
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The impact of CBP expression in estrogen receptor-positive breast cancer
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The impact of CBP expression in estrogen receptor-positive breast cancer
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
Estrogen receptor α polymorphisms and postmenopausal breast cancer risk
GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Author Correction: GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers
Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case–cohort analysis
The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
Local estrogen axis in the human bone microenvironment regulates estrogen receptor-positive breast cancer cells
The impact of CBP expression in estrogen receptor-positive breast cancer
HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women
microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
Role of BRD4 and histone acetylation in estrogen receptor-positive breast cancers
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer
Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer